Document is current
Any future updates will be listed below
-
Authors
Gale, Robert Peter https://orcid.org/0000-0002-9156-1676
Lazarus, Hillard M.
- License Information
-
More Information
Article History
Received: 24 July 2021
Revised: 7 September 2021
Accepted: 15 September 2021
First Online: 27 September 2021
COMPETING INTERESTS
: RPG is a consultant to Ascentage Pharma Group, BeiGene Ltd., Kite Pharma Inc., Fusion Pharma LLC, LaJolla NanoMedical Inc., Mingsight Parmaceuticals Inc., Prolacta Bioscience, Inc. and CStone Pharmaceuticals; Medical Director, FFF Enterprises Inc.; Partner, AZCA Inc.; Board of Directors, RakFond Foundation for Cancer Research Support; Scientific Advisory Board, Antengene Biotech LLC and StemRad Ltd. HML is a consultant to Partner Therapeutics, Pluristem Therapeutics, Actinium Pharmaceuticals, Jazz Pharmaceuticals, Seattle Genetics, a member of the Data Safety Monitoring Boards for Bristol-Myers Squibb-Celgene and BioSight, and a promotional speaker for AstraZeneca, Seattle Genetics and Jazz Pharmaceuticals.
Free to read: This content has been made available to all.
